subscribeSubscribe
price-trendAsk Us
Still under partial hold, Sanofi makes case for safety of MS med

Still under partial hold, Sanofi makes case for safety of MS med
Gabrielle Masson FIERCE BIOTECH
28 Apr 2023
Share Share
Tolebrutinib clinical trial program update

Tolebrutinib clinical trial program update
PRESS RELEASE
08 Aug 2022
Share Share
FDA sidelines Hudson`s $3.7B MS drug after establishing link to liver damage

FDA sidelines Hudson`s $3.7B MS drug after establishing link to liver damage
John Carroll ENDPTS
30 Jun 2022
Share Share
Sanofi moves MS patients out of Ukraine to maintain trial

Sanofi moves MS patients out of Ukraine to maintain trial
James Waldron FIERCEBIOTECH
29 Apr 2022
Share Share